Skip to content

AIM Market Roundup: Blue Star Capital, Trellus Health, Distil

AIM Market Roundup: Blue Star Capital, Trellus Health, Distil

At midday on Monday, the AIM All Share index remained under pressure down two points at 711.47 and threatening a retest of pre-Christmas lows. The last time we traded below 700 was in November 2023.

  • Blue Star Capital +50%
  • Trellus Health +23%
  • Distil +12%
  • tinyBuild -33%
  • Eagle Eye -23%

Blue Star Capital LON:BLU was leading the board mid-session with gains of 50%. Two stake building announcements this morning appear to have been the catalyst behind the move, although volumes are thin and the gain is in line with the currently quoted spread. The stock was consolidated last week, which is skewing performance figures.

Trellus Health LON:TRLS was in second place at our early copy time, up 23%. Last week, the company announced in a slightly under the radar way that they would be speaking at the JP Morgan healthcare conference which kicks off today, something that has form for giving stocks a boost.

Distil LON:DIS gets the notable mention, up 12%. The drinks company revealed this morning that Dr Graham Cooley – formerly CEO of ITM Power – had increased his stake in the company to give him 13.2% of the voting rights.

tinyBuild [LON:TBLS] was the biggest faller, off by 33% although there’s no news in play and no volume, so this is at least for now a calculation issue.

Eagle Eye Solutions LON:EYE was off 23% following corporate releases this morning. A multi-year global OEM deal which comes with opportunities for significant ARR contributions once live was noted, but the half year trading update came with a cautious tone, noting that a reduction in professional services revenues and longer lead times would result in income for FY 25 and 26 being 15% and 18% lower than expected.

Share this article

Invest with these platforms

Hargreaves Lansdown

IG

Interactive Brokers

Interactive Investor

Charles Stanley

IG

Interactive Brokers

Charles Stanley

Looking for great investing ideas? Get our free newsletter.
Join our UK news channel on WhatsApp

This article does not constitute investment advice.  Do your own research or consult a professional advisor.

Learn with our free 'How to' Guides

Our latest in-depth company reports

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
CME Group
FP Markets
Pepperstone
Schroders

TMX
WisdomTree
ARK
FxPro
CMC Markets
Back To Top